Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial
- PMID: 34310044
- PMCID: PMC9207984
- DOI: 10.1002/alz.12421
Mediterranean and Western diet effects on Alzheimer's disease biomarkers, cerebral perfusion, and cognition in mid-life: A randomized trial
Abstract
Introduction: Mid-life dietary patterns are associated with Alzheimer's disease (AD) risk, although few controlled trials have been conducted.
Methods: Eighty-seven participants (age range: 45 to 65) with normal cognition (NC, n = 56) or mild cognitive impairment (MCI, n = 31) received isocaloric diets high or low in saturated fat, glycemic index, and sodium (Western-like/West-diet vs. Mediterranean-like/Med-diet) for 4 weeks. Diet effects on cerebrospinal fluid (CSF) biomarkers, cognition, and cerebral perfusion were assessed to determine whether responses differed by cognitive status.
Results: CSF amyloid beta (Aβ)42/40 ratios increased following the Med-diet, and decreased after West-diet for NC adults, whereas the MCI group showed the reverse pattern. For the MCI group, the West-diet reduced and the Med-diet increased total tau (t-tau), whereas CSF Aβ42 /t-tau ratios increased following the West-diet and decreased following the Med-diet. For NC participants, the Med-diet increased and the West-diet decreased cerebral perfusion.
Discussion: Diet response during middle age may highlight early pathophysiological processes that increase AD risk.
Keywords: Alzheimer's disease; cerebral perfusion; cerebrospinal fluid biomarkers; diet intervention.
© 2021 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
S. Craft has received consulting fees and served as a scientific advisory board member for vTv Therapeutics, T3D Therapeutics, Cyclerion Therapeutics, and Cognito Therapeutics. Funding has been provided to her institution for research grants by NIH, the Alzheimer's Association, and Eli Lilly. A. Sanderlin had research funding provided to her institution by the Alzheimer's Association. Y. Jung had research funding provided to his institution by NIH, and holds US Patent 10,949,973 for which no payment has been received. J. Leverenz, S. Lockhart, A. Hanson, and T. Register had research funding provided to their institutions by the NIH. J. Leverenz had research funding provided to his institution by the Department of Veterans Affairs. S. Lockhart had travel funds provided to attend a conference by University of Texas Medical Branch. T. Register had travel funds provided by the Department of Defense.
Figures
References
-
- Pelkman CL. Effects of the glycemic index of foods on serum concentrations of high‐density lipoprotein cholesterol and triglycerides. Curr Atheroscler Rep. 2001;3:456‐461. - PubMed
